skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello 5i Team,

In an answer to a recent question about HESM, you stated:

"HESM is a US limited partnership, and has VERY onerous tax implications for Canadians..."

Is there a website that maintains an up-to-date list of US limited partnership stocks with additional tax implications for Canadian investors?

Thanks in advance for your always helpful advice!

Read Answer Asked by Keith on September 05, 2024
Q: The PE for this stock currently is around 43 and analysts are forecasting 30.5%/yr. growth in earnings over each of the next 5 years. Everything I read suggests this mag 7 stock is poised to go up and do phenomenal. To grow EPS 30.5%/yr for each of the next 5 years seems extremely optimistic to start with but even if it does the PEG ratio is 1.41 which suggests over valuation. The other mag 7 stocks with the exception of NVDA have much lower EPS growth rates at 20% max and dropping from there. How can one rationalize buying this stock now. Thank you. John
Read Answer Asked by John on September 05, 2024
Q: To Gary’s question on ranking your top silver plays, you answered: PAAS, MAG, AG. Why do you favour them and how would HL and AYA compare?
Read Answer Asked by Brian on September 05, 2024
Q: Could you please add FGRO ETF to your database.
I understood these 5 ETF's would have similar price performance but FGRO and TGRO outpace the other three for the last 3 Years. ZGRO, XGRO and VGRO pretty much have the same performance. Can you help explain why FGRO and TGRO have significantly outperformed the three?
Read Answer Asked by Ian on September 05, 2024
Q: Hi 5i Team,

Is there an ETF equivalent of RSP (S&P equal weight) that trades in Canada? If, not can you suggest a best alternative?

Thanks for the amazing service over the last 10+ years!

Angelo
Read Answer Asked by Angelo on September 04, 2024
Q: sanofi trades in a range over the long term. these days it seems to be either breaking out or topping its range. do you see this company dipping to its low end of its range ($45 ish) going forward or is a new higher range being formed.
Read Answer Asked by steve on September 04, 2024
Q: Hello, I would like to have your opinion on XHAK. I have been looking at buying a cybersecurity stock for some time, trying to decide between Palo Alto and Crowdstrike and some others. Could this ETF be a way in the sector? Looking at the portfolio, it includes some cos that don’t seem to be directly involved in cybersecurity, though. Not sure why these are included in this ETF… Thanks
Read Answer Asked by Martin on September 04, 2024
Q: Hi,
On September 4 in an answer to Ritwick's question, you said: "BCE did not cut its dividend in other times of crisis...".

I thought BCE cut its dividend by about half in 2008. It did raise the dividend again to previous trend levels in the subsequent year(s).

I vaguely recall at the time that the 2008 dividend cut was quite a dramatic move for a "widows and orphans' stock and of course no one could predict at the time the dividend would be reinstated the next year.

Cheers, Michael
Read Answer Asked by Michael on September 04, 2024
Q: Do you have any comments on ChromaDex Corp. (CDXC)? I see that Hamed Shahbazi is on the company's Nominating and Corporate Governance Committee.

Thanks
Read Answer Asked by Scott on September 04, 2024
Q: The Globe reports that Moody's just downgraded BCE. I understand that the downgrade means borrowing costs are higher. What else does it mean?

Do you think that BCE will have need to borrow money in the next couple of years.

Thanks a lot for your views.
Read Answer Asked by TOM on September 04, 2024
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!